Received Feb 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
first dose of SHINGRIX 8 years ago; diagnosed as shingles; This non-serious case was reported by a consumer via patient support programs and described the occurrence of shingles in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient did not receive the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, not applicable after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced shingles (Verbatim: diagnosed as shingles) and incomplete course of vaccination (Verbatim: first dose of SHINGRIX 8 years ago). The patient was treated with valaciclovir hydrochloride (Valtrex). The outcome of the shingles was resolved (duration 1 day) and the outcome of the incomplete course of vaccination was not applicable. It was unknown if the reporter considered the shingles to be related to Shingrix and Shingrix. It was unknown if the company considered the shingles to be related to Shingrix and Shingrix. Additional Information: GSK Receipt Date: 25-FEB-2025 The reporter stated he was vaccinated with his first dose of Shingrix 8 years ago. Consumer stated he had not had a second dose of Shingrix. Consumer stated last week he had a rash that was diagnosed as shingles. Consumer stated he was prescribed Valtrex and the rash cleared up in one day. Consumer stated he went to a different doctor and was told that he most likely did not have shingles. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.